Company profile
Pharma-Bio Serv, Inc.
OTC: PBSV · Industrials · Consulting Services
PublicHQ Dorado, PRCIK 0001304161Reports USD
#608 of 976 Industrials companies by revenue28th-percentile growth
EA Score
43DFH 53DQ 32GM 35SS 45
v0.1 · 65/100 weight · provisional
↑ balance-sheet leverage, growth stability · ↓ 3-yr revenue growth, filing timeliness
Methodology →Revenue TTM
$9.1M
Rev growth YoY (TTM)
-5.5%
Net income (FY)
-$100.5k
Employees
55
as of 2026-08-22
Market cap
$12.4M
as of 2026-08-22
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$9.0M$9.0M2025
Net income-$100.5k-$100.5k2025
Operating income-$637.7k-$637.7k2025
Total assets$13.7M$13.7M2025
Liabilities$1.7M$1.7M2025
Equity$11.9M$11.9M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Pharma-Bio Serv, Inc.’s revenue?
Pharma-Bio Serv, Inc. booked $9.0M in FY2025 revenue, contracting 5.3% year over year — slower than 72% of Industrials companies we track, at a -1.1% net margin.
Peers · Industrials
Ballistic Recovery Systems Inc.——Tel-Instrument Electronics Corp.——Zoomcar Holdings, Inc.——Sparta Capital Ltd.45DVie Financial Group, Inc.——American Defense Systems, Inc.——Key facts
CEOVictor Sanchez
SectorIndustrials
IndustryConsulting Services
HeadquartersDorado, PR
ExchangeOTC: PBSV
Employees55
IPO date2007-05-07
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.